Dissecting the cosubstrate structure requirements of the Staphylococcus aureus aminoglycoside resistance enzyme ANT(4′)

Vanessa R. Porter; Keith D. Green; Olga E. Zolova; Jacob L. Houghton; Sylvie Garneau-Tsodikova

doi:10.1016/j.bbrc.2010.10.119

Dissecting the cosubstrate structure requirements of the Staphylococcus aureus aminoglycoside resistance enzyme ANT(4′)

Vanessa R. Porter, Keith D. Green, Olga E. Zolova, Jacob L. Houghton, Sylvie Garneau-Tsodikova

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

Aminoglycosides are important antibiotics used against a wide range of pathogens. As a mechanism of defense, bacteria have evolved enzymes able to inactivate these drugs by regio-selectively adding a variety of functionalities (acetyl, phospho, and nucelotidyl groups) to their scaffolds. The aminoglycoside nucleotidyltransferase ANT(4′) is one of the most prevalent and unique modifying-enzymes. Here, by TLC, HRMS, and colorimetric assays, we demonstrate that the resistance enzyme ANT(4′) from Staphylococcus aureus is highly substrate and cosubstrate promiscuous. We show that deoxy-ribonucleotide triphosphates (dNTPs) are better cosubstrates than NTPs. We demonstrate that the position of the triphosphate group (5′ and not 3′) on the ribose/deoxyribose ring is important for recognition by ANT(4′), and that NTPs with larger substituents at the 3′-position of the ribose ring are not cosubstrates for ANT(4′). We confirm that for all aminoglycosides tested, the respective nucleotidylated products are completely inactive. These results provide valuable insights into the development of strategies to combat the ever-growing bacterial resistance problem.

Original language	English
Pages (from-to)	85-90
Number of pages	6
Journal	Biochemical and Biophysical Research Communications
Volume	403
Issue number	1
DOIs	https://doi.org/10.1016/j.bbrc.2010.10.119
State	Published - Dec 3 2010

Bibliographical note

Funding Information:
This work was supported by start-up funds from the LSI and the College of Pharmacy at the University of Michigan and by a BSF Grant 2008017 (S.G.T.). V.R.P. is the recipient of a Rackham Merit Fellowship. J.L.H. is supported by ACS Division of Medicinal Chemistry Predoctoral Fellowship sponsored by Eli Lilly and a 2010 BSF travel grant for young scientists. We thank Dr. Micha Fridman (Tel Aviv University, Israel) for his help with MS and Wenjing Chen for helping with the bioTLCs. We thank Dr. Juan L. Asensio for the pANT(4′)-pET28b plasmid.

Funding

This work was supported by start-up funds from the LSI and the College of Pharmacy at the University of Michigan and by a BSF Grant 2008017 (S.G.T.). V.R.P. is the recipient of a Rackham Merit Fellowship. J.L.H. is supported by ACS Division of Medicinal Chemistry Predoctoral Fellowship sponsored by Eli Lilly and a 2010 BSF travel grant for young scientists. We thank Dr. Micha Fridman (Tel Aviv University, Israel) for his help with MS and Wenjing Chen for helping with the bioTLCs. We thank Dr. Juan L. Asensio for the pANT(4′)-pET28b plasmid.

Funders	Funder number
Bloom's Syndrome Foundation	2008017
Eli Lilly and Company
University of Michigan Hospital
Institute of Life Sciences India

Keywords

Aminoglycoside
Antibacterial activity
Antibiotic
Bacterial resistance
Nucleotidyltransferase
Substrate and cosubstrate promiscuity

ASJC Scopus subject areas

Biophysics
Biochemistry
Molecular Biology
Cell Biology

Access to Document

10.1016/j.bbrc.2010.10.119

Cite this

@article{fe74bfa858b04111a65bbaf9270fac3c,

title = "Dissecting the cosubstrate structure requirements of the Staphylococcus aureus aminoglycoside resistance enzyme ANT(4′)",

abstract = "Aminoglycosides are important antibiotics used against a wide range of pathogens. As a mechanism of defense, bacteria have evolved enzymes able to inactivate these drugs by regio-selectively adding a variety of functionalities (acetyl, phospho, and nucelotidyl groups) to their scaffolds. The aminoglycoside nucleotidyltransferase ANT(4′) is one of the most prevalent and unique modifying-enzymes. Here, by TLC, HRMS, and colorimetric assays, we demonstrate that the resistance enzyme ANT(4′) from Staphylococcus aureus is highly substrate and cosubstrate promiscuous. We show that deoxy-ribonucleotide triphosphates (dNTPs) are better cosubstrates than NTPs. We demonstrate that the position of the triphosphate group (5′ and not 3′) on the ribose/deoxyribose ring is important for recognition by ANT(4′), and that NTPs with larger substituents at the 3′-position of the ribose ring are not cosubstrates for ANT(4′). We confirm that for all aminoglycosides tested, the respective nucleotidylated products are completely inactive. These results provide valuable insights into the development of strategies to combat the ever-growing bacterial resistance problem.",

keywords = "Aminoglycoside, Antibacterial activity, Antibiotic, Bacterial resistance, Nucleotidyltransferase, Substrate and cosubstrate promiscuity",

author = "Porter, {Vanessa R.} and Green, {Keith D.} and Zolova, {Olga E.} and Houghton, {Jacob L.} and Sylvie Garneau-Tsodikova",

note = "Funding Information: This work was supported by start-up funds from the LSI and the College of Pharmacy at the University of Michigan and by a BSF Grant 2008017 (S.G.T.). V.R.P. is the recipient of a Rackham Merit Fellowship. J.L.H. is supported by ACS Division of Medicinal Chemistry Predoctoral Fellowship sponsored by Eli Lilly and a 2010 BSF travel grant for young scientists. We thank Dr. Micha Fridman (Tel Aviv University, Israel) for his help with MS and Wenjing Chen for helping with the bioTLCs. We thank Dr. Juan L. Asensio for the pANT(4′)-pET28b plasmid. ",

year = "2010",

month = dec,

day = "3",

doi = "10.1016/j.bbrc.2010.10.119",

language = "English",

volume = "403",

pages = "85--90",

number = "1",

}

TY - JOUR

T1 - Dissecting the cosubstrate structure requirements of the Staphylococcus aureus aminoglycoside resistance enzyme ANT(4′)

AU - Porter, Vanessa R.

AU - Green, Keith D.

AU - Zolova, Olga E.

AU - Houghton, Jacob L.

AU - Garneau-Tsodikova, Sylvie

N1 - Funding Information: This work was supported by start-up funds from the LSI and the College of Pharmacy at the University of Michigan and by a BSF Grant 2008017 (S.G.T.). V.R.P. is the recipient of a Rackham Merit Fellowship. J.L.H. is supported by ACS Division of Medicinal Chemistry Predoctoral Fellowship sponsored by Eli Lilly and a 2010 BSF travel grant for young scientists. We thank Dr. Micha Fridman (Tel Aviv University, Israel) for his help with MS and Wenjing Chen for helping with the bioTLCs. We thank Dr. Juan L. Asensio for the pANT(4′)-pET28b plasmid.

PY - 2010/12/3

Y1 - 2010/12/3

N2 - Aminoglycosides are important antibiotics used against a wide range of pathogens. As a mechanism of defense, bacteria have evolved enzymes able to inactivate these drugs by regio-selectively adding a variety of functionalities (acetyl, phospho, and nucelotidyl groups) to their scaffolds. The aminoglycoside nucleotidyltransferase ANT(4′) is one of the most prevalent and unique modifying-enzymes. Here, by TLC, HRMS, and colorimetric assays, we demonstrate that the resistance enzyme ANT(4′) from Staphylococcus aureus is highly substrate and cosubstrate promiscuous. We show that deoxy-ribonucleotide triphosphates (dNTPs) are better cosubstrates than NTPs. We demonstrate that the position of the triphosphate group (5′ and not 3′) on the ribose/deoxyribose ring is important for recognition by ANT(4′), and that NTPs with larger substituents at the 3′-position of the ribose ring are not cosubstrates for ANT(4′). We confirm that for all aminoglycosides tested, the respective nucleotidylated products are completely inactive. These results provide valuable insights into the development of strategies to combat the ever-growing bacterial resistance problem.

AB - Aminoglycosides are important antibiotics used against a wide range of pathogens. As a mechanism of defense, bacteria have evolved enzymes able to inactivate these drugs by regio-selectively adding a variety of functionalities (acetyl, phospho, and nucelotidyl groups) to their scaffolds. The aminoglycoside nucleotidyltransferase ANT(4′) is one of the most prevalent and unique modifying-enzymes. Here, by TLC, HRMS, and colorimetric assays, we demonstrate that the resistance enzyme ANT(4′) from Staphylococcus aureus is highly substrate and cosubstrate promiscuous. We show that deoxy-ribonucleotide triphosphates (dNTPs) are better cosubstrates than NTPs. We demonstrate that the position of the triphosphate group (5′ and not 3′) on the ribose/deoxyribose ring is important for recognition by ANT(4′), and that NTPs with larger substituents at the 3′-position of the ribose ring are not cosubstrates for ANT(4′). We confirm that for all aminoglycosides tested, the respective nucleotidylated products are completely inactive. These results provide valuable insights into the development of strategies to combat the ever-growing bacterial resistance problem.

KW - Aminoglycoside

KW - Antibacterial activity

KW - Antibiotic

KW - Bacterial resistance

KW - Nucleotidyltransferase

KW - Substrate and cosubstrate promiscuity

UR - http://www.scopus.com/inward/record.url?scp=78649713996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649713996&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.10.119

DO - 10.1016/j.bbrc.2010.10.119

M3 - Article

C2 - 21040710

AN - SCOPUS:78649713996

SN - 0006-291X

VL - 403

SP - 85

EP - 90

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

IS - 1

ER -

Dissecting the cosubstrate structure requirements of the Staphylococcus aureus aminoglycoside resistance enzyme ANT(4′)

Abstract

Bibliographical note

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this